MedTrace Logo

Detecting Auricular Points in MMG by a Novel APD ( APD-MMG )

NCT03702114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2018-10-10

No results posted yet for this study

Summary

This pilot study is designed to validate the diagnostic ability of a novel APD for auricular point detection among patients with menstrual migraine (MMG), as compared with an already commercialized device.

Conditions

  • Menstrual Migraine

Interventions

DEVICE

auricular point detection

This device is only for auricular detection. No additional intervention will be delivered.

Sponsors & Collaborators

  • Queen Mary Hospital, Hong Kong

    collaborator OTHER

  • City University of Hong Kong

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Lixing Lao · The University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2019-01-31
Completion
2019-03-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03702114 on ClinicalTrials.gov